Over the last 24 years the strategic alliance has evolved into a tool with which pharmaceutical companies effectively exploit and share technologies and products. Strategic alliances in the 21st century have increased both in number and value. The growth in the number of alliances has been driven by companies expanding networks of partner companies. That companies are spending up to $2bn to secure these relationships highlights the critical strategic importance of alliances within the current competitive environment. The new management report, Pharmaceutical Strategic Alliances: Benchmarking 21st century deal-making, by Business Insights, provides a detailed review of alliance and licensing activity since the beginning of 2000 in order to identify current trends and best practices. The report provides a comprehensive benchmarking analysis through which companies can make more informed decisions with respect to alliances, therapies, technologies and competitors.
ISBN 1-84296-215-9
Published: November 2002 - Global. |
